Evolution of Medical Device OEM

How Technology Sharing Reshapes Brand Competitiveness?

When OEM Is No Longer Just Contract Manufacturing: How Konlida’s Technology Transfer Model Shortens Time-to-Market for Medical Device Companies

I. Core Logic of Technology Transfer

In the traditional OEM model, brand owners must independently complete R&D, registration, and production, a cycle lasting 18–24 months. Konlida Medical, through its “technology module reuse” mechanism, transfers mature technical parameters from its own products (e.g., dressing absorbency, adhesive strength, material crosslinking degree) to customized products for clients, significantly compressing R&D and registration timelines. Case in point: A medical aesthetics brand reused Konlida’s silicone dressing crosslinking technology (Patent No.: ZL202010201234.5) needing only supplementary biocompatibility testing, reducing time-to-market from 18 months to 7 months and cutting R&D costs by 60%.

II. Transferable Technology Module Library

01 Hydrofiber Dressing Technology Platform
Core Parameter: Absorbency up to 20 times the dressing’s own weight (modified sodium carboxymethyl cellulose)
Reuse Value: Accelerates development of post-operative care products, eliminates redundant verification of absorbency performance
Supported by Registration Certificate: Su-Xie-Zhu-Zhun 20222142118 (covers full specification range from 5×5 cm to 15×15 cm)

02 Medical Silicone Gel Scar Dressing Technology Platform
Core Parameter: Crosslinking degree 65%±2% (controlling silicone release rate at 0.8 mg/cm²/24h)
Reuse Value: Directly draws on biocompatibility data from registered files, saving six months of testing
Supported by Registration Certificate: Su-Xie-Zhu-Zhun 20252140367 (supports 56 specifications, from Φ1 cm to 15×5 cm)

03 Sutureless Closure Device Technology Platform
Core Parameter: Self-locking tension-relieving structure (Patent No.: ZL20222022028.6)
Reuse Value: Eliminates need to revalidate mechanical properties for non-invasive suturing device development

III. Compliance Path for Technology Transfer

Key Guarantees:
Risk Isolation: Konlida assumes production system compliance (GMP/ISO13485), while brand owners retain intellectual property rights.
Global Certification Reuse: Supports technology transfer under both China NMPA and US FDA (manufacturing facility certified to Class 100,000 cleanroom standards).

IV. Client Benefit Quantification Model

Compliance Statement
Technical Parameter Sources:

• Absorbency Data: Laboratory Report No. KLL-SY202301

• Crosslinking Data: Patent ZL202010201234.5